Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment

References

• Agarwal S, Boddu SH, Jain R, et al. (2008). Peptide prodrugs: improved oral absorption of lopinavir, a HIV protease inhibitor. Int J Pharm 359:7–14
   PubMed Web of Science ®Google Scholar
• Ahuja G, Pathak K. (2009). Porous carriers for controlled/modulated drug delivery. Indian J Pharm Sci 71:599
   PubMed Web of Science ®Google Scholar
• Aji Alex MR, Chacko AJ, Jose S, et al. (2011). Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci 42:11–18
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Lee BJ, Oh DH, et al. (2009). Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm 72:539–45
   PubMed Web of Science ®Google Scholar
• Basalious EB, Shawky N, Badr-Eldin SM. (2010). SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm 391:203–11
   PubMed Web of Science ®Google Scholar
• Beg S, Sandhu PS, Batra RS, et al. (2015). QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance. Drug Deliv 22:765–84
   PubMed Web of Science ®Google Scholar
• Beg S, Swain S, Singh HP, et al. (2012). Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech 13:1416–27
   PubMed Web of Science ®Google Scholar
• Brunton L, Chabner B, Knollman B. (2011). Goodman and Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill Education
   Google Scholar
• Caliph SM, Charman WN, Porter CJ. (2000). Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci 89:1073–84
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N, Zastre J, Wong HL, et al. (2008). Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm Res 25:2262–71
   PubMed Web of Science ®Google Scholar
• Chen ML. (2008). Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv Drug Deliv Rev 60:768–77
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen C, Zheng J, et al. (2011). Development of a solid supersaturatable self-emulsifying drug delivery system of docetaxel with improved dissolution and bioavailability. Biol Pharm Bull 34:278–86
   PubMed Web of Science ®Google Scholar
• Cho W, Kim MS, Kim JS, et al. (2013). Optimized formulation of solid self-microemulsifying sirolimus delivery systems. Int J Nanomedicine 8:1673–82
   PubMed Web of Science ®Google Scholar
• Chudasama A, Patel V, Nivsarkar M, et al. (2015). Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations. Drug Deliv 22:531–40
   PubMed Web of Science ®Google Scholar
• Constantinides PP. (1995). Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 12:1561–72
   PubMed Web of Science ®Google Scholar
• Date AA, Nagarsenker MS. (2007). Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm 329:166–72
   PubMed Web of Science ®Google Scholar
• Ding W, Hou X, Cong S, et al. (2015). Co-delivery of honokiol, a constituent of Magnolia species, in a self-microemulsifying drug delivery system for improved oral transport of lipophilic sirolimus. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2015.1020119
   Web of Science ®Google Scholar
• Elnaggar YS, El-Massik MA, Abdallah OY. (2009). Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm 380:133–41
   PubMed Web of Science ®Google Scholar
• Flexner C, Tierney C, Gross R, et al. (2010). Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clin Infect Dis 50:1041–52
   PubMed Web of Science ®Google Scholar
• Gao P, Witt MJ, Haskell RJ, et al. (2004). Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load. Pharm Dev Technol 9:301–9
   PubMed Web of Science ®Google Scholar
• Griffin BT, O’Driscoll CM. (2008). An examination of the effect of intestinal first pass extraction on intestinal lymphatic transport of saquinavir in the rat. Pharm Res 25:1125–33
   PubMed Web of Science ®Google Scholar
• Gupta S, Chavhan S, Sawant KK. (2011). Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A Physicochem Eng Asp 392:145–55
   Web of Science ®Google Scholar
• Holm R, Jensen IH, Sonnergaard J. (2006). Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function. Drug Dev Ind Pharm 32:1025–32
   PubMed Web of Science ®Google Scholar
• Hsu A, Isaacson J, Brun S, et al. (2003). Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 47:350–9
   PubMed Web of Science ®Google Scholar
• Huang Y-B, Tsai YH, Lee SH, et al. (2005). Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm 289:87–95
   PubMed Web of Science ®Google Scholar
• Inugala S, Eedara BB, Sunkavalli S, et al. (2015). Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: in vitro and in vivo evaluation. Eur J Pharm Sci 74:1–10
   PubMed Web of Science ®Google Scholar
• Jain V, Prasad V, Jadhav P, et al. (2009). Preparation and performance evaluation of saquinavir laden cationic submicron emulsions. Drug Deliv 16:37–44
   PubMed Web of Science ®Google Scholar
• Li F, Song S, Guo Y, et al. (2015). Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam. Drug Deliv 22:487–98
   PubMed Web of Science ®Google Scholar
• Max B, Sherer R. (2000). Management of the adverse effects of antiretroviral therapy and medication adherence. Clin Infect Dis 30:S96–116
   PubMed Web of Science ®Google Scholar
• Milović M, Djuriš J, Djekić L, et al. (2012). Characterization and evaluation of solid self-microemulsifying drug delivery systems with porous carriers as systems for improved carbamazepine release. Int J Pharm 436:58–65
   PubMed Web of Science ®Google Scholar
• Mohd AB, Sanka K, Bandi S, et al. (2015). Solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of glimepiride: development and antidiabetic activity in albino rabbits. Drug Deliv 22:499–508
   PubMed Web of Science ®Google Scholar
• Mou D, Chen H, Du D, et al. (2008). Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs. Int J Pharm 353:270–6
   PubMed Web of Science ®Google Scholar
• Nazzal S, Smalyukh I, Lavrentovich O, et al. (2002). Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm 235:247–65
   PubMed Web of Science ®Google Scholar
• Patel D, Sawant KK. (2007). Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev Ind Pharm 33:1318–26
   PubMed Web of Science ®Google Scholar
• Patel J, Dhingani A, Garala K, et al. (2014). Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets. Drug Deliv 21:412–35
   PubMed Web of Science ®Google Scholar
• Patel J, Patel A, Raval M, et al. (2011). Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan. J Adv Pharm Technol Res 2:9–16
   PubMedGoogle Scholar
• Porter CJ, Pouton CW, Cuine JF, et al. (2008). Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev 60:673–91
   PubMed Web of Science ®Google Scholar
• Pouton CW. (2000). Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci 11:S93–8
   PubMed Web of Science ®Google Scholar
• Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 29:278–87
   PubMed Web of Science ®Google Scholar
• Rane SS, Anderson BD. (2008). What determines drug solubility in lipid vehicles: is it predictable? Adv Drug Deliv Rev 60:638–56
   PubMed Web of Science ®Google Scholar
• Rao SV, Shao J. (2008). Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development. Int J Pharm 362:2–9
   PubMed Web of Science ®Google Scholar
• Ravi PR, Vats R, Dalal V, et al. (2014). A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation. J Pharm Pharmacol 66:912–26
   PubMed Web of Science ®Google Scholar
• Ravi PR, Vats R, Dalal V, et al. (2015). Design, optimization and evaluation of poly-ɛ-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir. Drug Dev Ind Pharm 41:131–40
   PubMed Web of Science ®Google Scholar
• Scheffe H. (1958). Experiments with mixtures. J Roy Statist Soc Ser B 20:344–60
   Google Scholar
• Shao B, Cui C, Ji H, et al. (2014). Enhanced oral bioavailability of piperine by self-emulsifying drug delivery systems: in vitro, in vivo and in situ intestinal permeability studies. Drug Deliv 22:740–7
   PubMed Web of Science ®Google Scholar
• Singh B, Khurana L, Bandyopadhyay S, et al. (2011). Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential. Drug Deliv 18:599–612
   PubMed Web of Science ®Google Scholar
• Singh B, Singh R, Bandyopadhyay S, et al. (2013). Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids Surf B Biointerfaces 101:465–74
   PubMed Web of Science ®Google Scholar
• Swenson ES, Milisen WB, Curatolo W. (1994). Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm Res 11:1132–42
   PubMed Web of Science ®Google Scholar
• Taha EI, Al-Saidan S, Samy AM, et al. (2004). Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int J Pharm 285:109–19
   PubMed Web of Science ®Google Scholar
• Tiwari R, Agarwa R, et al, Kailya JR. (2012). Process for the preparation of solid dispersion of lopinavir and ritonavir. Google Patents
   Google Scholar
• Vats R, Murthy AN, Ravi PR. (2011). Simple, rapid and validated LC determination of lopinavir in rat plasma and its application in pharmacokinetic studies. Sci Pharm 79:849–63
   PubMedGoogle Scholar
• Wang L, Dong J, Chen J, et al. (2009). Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 330:443–8
   PubMed Web of Science ®Google Scholar
• Wang Z, Sun J, Wang Y, et al. (2010). Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm 383:1–6
   PubMed Web of Science ®Google Scholar
• Wasan EK, Bartlett K, Gershkovich P, et al. (2009). Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans. Int J Pharm 372:76–84
   PubMed Web of Science ®Google Scholar
• Wu Z, Guo D, Deng L, et al. (2011). Preparation and evaluation of a self-emulsifying drug delivery system of etoposide-phospholipid complex. Drug Dev Ind Pharm 37:103–12
   PubMed Web of Science ®Google Scholar
• Yu L, Bridgers A, Polli J, et al. (1999). Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res 16:1812–7
   PubMed Web of Science ®Google Scholar
• Zang XX Q, Gu N. (2006). Preparation of All-Trans Retinoic Acid nanosuspensions using a modified precipitation method. Drug Dev Ind Pharm 32:857–63
   PubMed Web of Science ®Google Scholar